Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

6 Dimensions Capital

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
Shanghai, China
Countries of investment
  • China
Investment stages
  • Seed
Industries
  • Manufacturing
  • Pharmaceuticals
  • Biotechnology
  • HealthCare
  • Therapeutics
About
6 Dimensions Capital is a leading global healthcare investment firm with offices in Boston, San Francisco, Hong Kong, and Shanghai. The firm focuses on investing in healthcare startups and growth-stage companies worldwide, enabling entrepreneurs to create transformative solutions.
Min check size
$1M
Max check size
$20M
Fund size
NPS

Investment Thesis

6 Dimensions Capital specializes in healthcare investments, aiming to drive advancements in this critical sector by supporting innovative companies at various stages of their development. The firm seeks to invest in companies with promising technologies and solutions that address key healthcare challenges.
Lead investor
Co Invest
Number of exits
Preferred contact method

6 Dimensions Capital Contacts Information

Primary contact

Secondary contact

Portfolio

AnchorDx

BeiGene

Ltd.

BioKangtai Biologics

Birdie Biopharmaceuticals

Brii Biosciences

CStone Pharmaceuticals

Coherent Biopharma

Curon

Cutia

Engine Biosciences

Fog Pharmaceuticals

Forerunner Medical

Fulcrum Therapeutics

GRAIL

Gloria Biosciences

GloriousMed

Gracell Bio

Guoke-Hengtai

Haoxinqing

Hua MedTech

Hua Medicine

Ideaya Biosciences

Innovent Biologics

iTeos Therapeutics

Kira Pharma

Kymera Therapeutics

LifeMine Therapeutics

Lyvgen

M6P Therapeutics

MID Labs

MYZH

Mabsoft

MitrAssist

Nanos Medical

Neusoft Medical

OcuMension

PICA Health Technologies

Prudence Medical Technologies Ltd.

Realton Medtech

Semma Therapeutics

Shanghai Huazhou

Sino Health

Syros Pharmaceuticals

TCR2 Therapeutics

TScan Therapeutics

TenNor Therapeutics

Twist Bioscience

Unity Biotechnology

Viela Bio

Vivace Therapeutics

WellVac Biotech

Xikang

Yikon Genomics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp